{"id":79404,"date":"2026-09-08T12:33:07","date_gmt":"2026-09-08T04:33:07","guid":{"rendered":"https:\/\/flcube.com\/?p=79404"},"modified":"2026-09-08T12:33:08","modified_gmt":"2026-09-08T04:33:08","slug":"china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation","status":"publish","type":"post","link":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/","title":{"rendered":"China Biotech&#8217;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Panboron (Hainan) BNCT Hospital<\/strong>, a subsidiary of <strong>China Biotech Services Holdings Limited<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/8037:HKG\">HKG: 8037<\/a>), officially signed a <strong>strategic cooperation agreement<\/strong> with <strong>OncoCare Cancer Centre HK<\/strong> on <strong>September 2, 2026<\/strong>. The two parties will jointly build a <strong>cross\u2011border oncology diagnosis and treatment collaboration mechanism<\/strong>, launching <strong>international medical cooperation for BNCT (Boron Neutron Capture Therapy)<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-deal-milestone\" class=\"wp-block-heading\">Deal Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Party A<\/strong><\/td><td>Panboron (Hainan) BNCT Hospital \u2014 subsidiary of China Biotech Services Holdings (HKG: 8037)<\/td><\/tr><tr><td><strong>Party B<\/strong><\/td><td>OncoCare Cancer Centre HK<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Strategic cooperation agreement<\/td><\/tr><tr><td><strong>Signing Date<\/strong><\/td><td>2 Sep 2026<\/td><\/tr><tr><td><strong>Scope<\/strong><\/td><td>Cross\u2011border oncology diagnosis &amp; treatment collaboration for BNCT<\/td><\/tr><tr><td><strong>Location Advantage<\/strong><\/td><td>Boao Lecheng International Medical Tourism Pilot Zone, Hainan<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-collaboration-framework-full-chain-service-mechanism\" class=\"wp-block-heading\">Collaboration Framework \u2014 Full\u2011Chain Service Mechanism<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The agreement establishes an <strong>&#8220;offshore evaluation + onshore treatment + offshore follow\u2011up&#8221;<\/strong> full\u2011chain service mechanism:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Function<\/th><th>Responsible Party<\/th><\/tr><\/thead><tbody><tr><td><strong>Public science communication overseas<\/strong><\/td><td>OncoCare Cancer Centre HK<\/td><\/tr><tr><td><strong>Initial patient screening &amp; evaluation<\/strong><\/td><td>OncoCare Cancer Centre HK<\/td><\/tr><tr><td><strong>Service coordination<\/strong><\/td><td>OncoCare Cancer Centre HK<\/td><\/tr><tr><td><strong>Post\u2011treatment offshore follow\u2011up management<\/strong><\/td><td>OncoCare Cancer Centre HK<\/td><\/tr><tr><td><strong>BNCT clinical treatment in China&#8217;s mainland<\/strong><\/td><td>Panboron (Hainan) BNCT Hospital<\/td><\/tr><tr><td><strong>Inpatient management<\/strong><\/td><td>Panboron (Hainan) BNCT Hospital<\/td><\/tr><tr><td><strong>Medical quality &amp; safety<\/strong><\/td><td>Panboron (Hainan) BNCT Hospital<\/td><\/tr><tr><td><strong>Real\u2011time diagnosis &amp; treatment progress sharing<\/strong><\/td><td>Panboron (Hainan) BNCT Hospital<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-profile-boron-neutron-capture-therapy-bnct\" class=\"wp-block-heading\">Technology Profile \u2014 Boron Neutron Capture Therapy (BNCT)<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Modality:<\/strong> A form of <strong>precision radiotherapy<\/strong> operating at the <strong>cellular scale<\/strong><\/li>\n\n\n\n<li><strong>Mechanism:<\/strong> Targeted <strong>boron drugs<\/strong> accumulate boron\u201110 within cancer cells; <strong>epithermal neutron beam irradiation<\/strong> then triggers a nuclear reaction that <strong>&#8220;point\u2011destroys&#8221; cancer cells<\/strong> while sparing surrounding normal tissues<\/li>\n\n\n\n<li><strong>Equipment:<\/strong> Japan&#8217;s <strong>NeuCure neutron irradiation system<\/strong><\/li>\n\n\n\n<li><strong>Drug:<\/strong> <strong>Steboronine<\/strong> boron pharmaceutical<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-approved-indications-amp-regulatory-pipeline\" class=\"wp-block-heading\">Approved Indications &amp; Regulatory Pipeline<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Status<\/th><th>Indication<\/th><\/tr><\/thead><tbody><tr><td><strong>Approved (current)<\/strong><\/td><td><strong>Unresectable locally advanced or recurrent head and neck cancers<\/strong> \u2014 covering over ten subtypes, including <strong>nasopharyngeal, paranasal sinus, laryngeal, and oral cavity cancers<\/strong><\/td><\/tr><tr><td><strong>Expected by end of 2026<\/strong><\/td><td><strong>High\u2011grade recurrent meningioma<\/strong> (additional indication, approval anticipated)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cross\u2011Border Medical Tourism Play:<\/strong> The partnership positions Panboron to capture international \u2014 particularly Greater China and Southeast Asian \u2014 patient inflow through Hainan&#8217;s <strong>Boao Lecheng International Medical Tourism Pilot Zone<\/strong>, China&#8217;s designated zone for early access to imported drugs and devices.<\/li>\n\n\n\n<li><strong>Full\u2011Chain Model:<\/strong> The offshore\/onshore division of labor mirrors the <strong>&#8220;evaluation\u2013treatment\u2013follow\u2011up&#8221; continuum<\/strong> increasingly adopted in cross\u2011border precision medicine, addressing a key barrier for overseas patients seeking treatment in China&#8217;s mainland.<\/li>\n\n\n\n<li><strong>Indication Expansion:<\/strong> Approval of the <strong>high\u2011grade recurrent meningioma<\/strong> indication by year\u2011end would broaden BNCT&#8217;s addressable patient population beyond head and neck oncology into neuro\u2011oncology.<\/li>\n\n\n\n<li><strong>Listed\u2011Company Exposure:<\/strong> For <strong>China Biotech Services Holdings<\/strong> (HKG: 8037), the agreement extends its CRO\u2011anchored business into clinical treatment services and international patient channels.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding regulatory approvals, cross\u2011border patient volumes, and commercialization of BNCT services. Actual results may differ due to risks including regulatory timelines, treatment capacity, market adoption, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially&#8230;<\/p>\n","protected":false},"author":1,"featured_media":79406,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,4908],"tags":[4932,4933,4931],"class_list":["post-79404","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-pic","tag-china-biotech-services","tag-hkg-8037","tag-panboron-bnct-hospital"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China Biotech&#039;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially signed a strategic cooperation agreement with OncoCare Cancer Centre HK on September 2, 2026. The two parties will jointly build a cross\u2011border oncology diagnosis and treatment collaboration mechanism, launching international medical cooperation for BNCT (Boron Neutron Capture Therapy).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Biotech&#039;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation\" \/>\n<meta property=\"og:description\" content=\"Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially signed a strategic cooperation agreement with OncoCare Cancer Centre HK on September 2, 2026. The two parties will jointly build a cross\u2011border oncology diagnosis and treatment collaboration mechanism, launching international medical cooperation for BNCT (Boron Neutron Capture Therapy).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-08T04:33:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T04:33:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China Biotech&#8217;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation\",\"datePublished\":\"2026-09-08T04:33:07+00:00\",\"dateModified\":\"2026-09-08T04:33:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/\"},\"wordCount\":491,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0802.webp\",\"keywords\":[\"China Biotech Services\",\"HKG: 8037\",\"Panboron BNCT Hospital\"],\"articleSection\":[\"Company\",\"Deals\",\"PIC\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/\",\"name\":\"China Biotech's Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0802.webp\",\"datePublished\":\"2026-09-08T04:33:07+00:00\",\"dateModified\":\"2026-09-08T04:33:08+00:00\",\"description\":\"Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially signed a strategic cooperation agreement with OncoCare Cancer Centre HK on September 2, 2026. The two parties will jointly build a cross\u2011border oncology diagnosis and treatment collaboration mechanism, launching international medical cooperation for BNCT (Boron Neutron Capture Therapy).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0802.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0802.webp\",\"width\":1080,\"height\":608,\"caption\":\"China Biotech's Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China Biotech&#8217;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/author\\\/wesley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China Biotech's Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation - Insight, China&#039;s Pharmaceutical Industry","description":"Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially signed a strategic cooperation agreement with OncoCare Cancer Centre HK on September 2, 2026. The two parties will jointly build a cross\u2011border oncology diagnosis and treatment collaboration mechanism, launching international medical cooperation for BNCT (Boron Neutron Capture Therapy).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/","og_locale":"en_US","og_type":"article","og_title":"China Biotech's Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation","og_description":"Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially signed a strategic cooperation agreement with OncoCare Cancer Centre HK on September 2, 2026. The two parties will jointly build a cross\u2011border oncology diagnosis and treatment collaboration mechanism, launching international medical cooperation for BNCT (Boron Neutron Capture Therapy).","og_url":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-09-08T04:33:07+00:00","article_modified_time":"2026-09-08T04:33:08+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#article","isPartOf":{"@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China Biotech&#8217;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation","datePublished":"2026-09-08T04:33:07+00:00","dateModified":"2026-09-08T04:33:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/"},"wordCount":491,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp","keywords":["China Biotech Services","HKG: 8037","Panboron BNCT Hospital"],"articleSection":["Company","Deals","PIC"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/","url":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/","name":"China Biotech's Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp","datePublished":"2026-09-08T04:33:07+00:00","dateModified":"2026-09-08T04:33:08+00:00","description":"Panboron (Hainan) BNCT Hospital, a subsidiary of China Biotech Services Holdings Limited (HKG: 8037), officially signed a strategic cooperation agreement with OncoCare Cancer Centre HK on September 2, 2026. The two parties will jointly build a cross\u2011border oncology diagnosis and treatment collaboration mechanism, launching international medical cooperation for BNCT (Boron Neutron Capture Therapy).","breadcrumb":{"@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp","width":1080,"height":608,"caption":"China Biotech's Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/china-biotechs-panboron-bnct-hospital-signs-strategic-pact-with-oncocare-cancer-centre-hk-launching-cross-border-bnct-oncology-cooperation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China Biotech&#8217;s Panboron BNCT Hospital Signs Strategic Pact with OncoCare Cancer Centre HK \u2013 Launching Cross\u2011Border BNCT Oncology Cooperation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/author\/wesley\/"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0802.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/comments?post=79404"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79404\/revisions"}],"predecessor-version":[{"id":79407,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79404\/revisions\/79407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/media\/79406"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/media?parent=79404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/categories?post=79404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/tags?post=79404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}